<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04213638</url>
  </required_header>
  <id_info>
    <org_study_id>1120191113</org_study_id>
    <nct_id>NCT04213638</nct_id>
  </id_info>
  <brief_title>Trial of Single Microneedle Radiofrequency for Moderate‐to‐Severe Acne Vulgaris</brief_title>
  <official_title>Randomized Controlled Trial of Single Microneedle Radiofrequency for Moderate‐to‐Severe Acne Vulgaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xiangya Hospital of Central South University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to testify the efficacy of treating moderate‐to‐severe acne
      vulgaris with Single Microneedle Radiofrequency, and provide evidence for the hypothesis that
      &quot;whether Single Microneedle Radiofrequency therapy could be an alternative to photodynamic
      therapy for moderate to severe acne vulgaris.&quot;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to testify whether Single Microneedle Radiofrequency is effective
      for moderate‐to‐severe acne vulgaris, through treating moderate‐to‐severe acne vulgaris
      patient for 1 month, using photodynamic therapy as controlled group, and try to provide
      clinical evidence for the hypothesis that &quot;whether Single Microneedle Radiofrequency therapy
      could be an alternative to photodynamic therapy for moderate to severe acne vulgaris.&quot;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2019</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The reduction rate of number of acne lesions</measure>
    <time_frame>16 weeks</time_frame>
    <description>Measure the reduction rate of number of acne lesions at 16 weeks after treatment compared with a baseline</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">122</enrollment>
  <condition>Acne Vulgaris</condition>
  <arm_group>
    <arm_group_label>Group：1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Other：Single Microneedle Radiofrequency therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group：2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention: Other：Photodynamic therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Single Microneedle Radiofrequency therapy</intervention_name>
    <description>Subjects are treated with three consecutive sessions of Single Microneedle Radiofrequency therapy at 2‐week intervals, with a follow‐up visit 12 weeks after the final third treatment. Each treatment session took approximately 30-60 minutes.</description>
    <arm_group_label>Group：1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Photodynamic therapy</intervention_name>
    <description>Subjects are treated with three consecutive sessions of Photodynamic therapy at 2‐week intervals, with a follow‐up visit 12 weeks after the final third treatment.</description>
    <arm_group_label>Group：2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Consistent with the diagnostic criteria of moderate‐to‐severe acne vulgaris (IGA3-4) .

          2. Age of a subject is older than 14 and is younger than 45.（including 14 and 45）.

          3. Did not take any anti‐acne treatment in the last 1 month, and did not take part in any
             clinical trial.

          4. Informed consent is signed by a subject or his lineal relation.

        Exclusion Criteria:

          1. systemic acne treatment with oral isotretinoin within 6 months or oral antibiotics in
             the past 1 month;

          2. history of facial procedures like dermabrasion, chemical, or laser peels;

          3. history of photosensitive diseases, porphyria, or porphyrin sensitivity.

          4. With serious protopathy or disease of cardiovascular, liver, renal, gastrointestinal,
             hematological systems and so on.

          5. Pregnant women or women in lactation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Xiang Ya Hospital Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Jian, Doctor</last_name>
      <phone>18175103373</phone>
      <email>mengping@csu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Lynn DD, Umari T, Dunnick CA, Dellavalle RP. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther. 2016 Jan 19;7:13-25. doi: 10.2147/AHMT.S55832. eCollection 2016. Review.</citation>
    <PMID>26955297</PMID>
  </reference>
  <reference>
    <citation>Xing M, Yan X, Sun X, Wang S, Zhou M, Zhu B, Kuai L, Liu L, Luo Y, Li X, Li B. Fire needle therapy for moderate-severe acne: A PRISMA systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2019 Jun;44:253-260. doi: 10.1016/j.ctim.2019.04.009. Epub 2019 Apr 28.</citation>
    <PMID>31126563</PMID>
  </reference>
  <reference>
    <citation>Tang X, Li C, Ge S, Chen Z, Lu L. Efficacy of photodynamic therapy for the treatment of inflammatory acne vulgaris: A systematic review and meta-analysis. J Cosmet Dermatol. 2020 Jan;19(1):10-21. doi: 10.1111/jocd.13197. Epub 2019 Oct 25. Review.</citation>
    <PMID>31654468</PMID>
  </reference>
  <reference>
    <citation>Ahn GR, Kim JM, Park SJ, Li K, Kim BJ. Selective Sebaceous Gland Electrothermolysis Using a Single Microneedle Radiofrequency Device for Acne Patients: A Prospective Randomized Controlled Study. Lasers Surg Med. 2020 Jun;52(5):396-401. doi: 10.1002/lsm.23152. Epub 2019 Sep 10.</citation>
    <PMID>31502662</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 26, 2019</study_first_submitted>
  <study_first_submitted_qc>December 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 30, 2019</study_first_posted>
  <last_update_submitted>December 27, 2019</last_update_submitted>
  <last_update_submitted_qc>December 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

